| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
55,700,000 |
| Market
Cap: |
2.36(B) |
| Last
Volume: |
541,970 |
Avg
Vol: |
426,665 |
| 52
Week Range: |
$29.07 - $42.4 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile AtriCure provides treatments for atrial fibrillation (Afib), left atrial appendage management and post-operative pain. Co.'s ablation and left atrial appendage management products are used by physicians during both open-heart and minimally invasive procedures. Co.'s Isolator® Synergy Ablation System is approved by U.S. Food and Drug Administration (FDA) for the treatment of persistent and long-standing persistent Afib concomitant to other open-heart surgical procedures. The EPi-Sense® system is approved by FDA to treat patients with long-standing persistent Afib. All of Co.'s other ablation devices are cleared for sale in U.S., including its other radio frequency and cryoablation products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$111,250 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
18,166 |
36,118 |
44,718 |
62,834 |
| Total Sell Value |
$676,378 |
$1,332,011 |
$1,648,143 |
$2,237,320 |
| Total People Sold |
3 |
5 |
6 |
7 |
| Total Sell Transactions |
4 |
9 |
11 |
17 |
| End Date |
2025-09-14 |
2025-06-13 |
2024-12-13 |
2023-12-14 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Carrel Michael H |
President, CEO, & Director |
|
2025-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
687,377 |
|
- |
|
Noznesky Justin J |
Chief Mktg & Strategy Officer |
|
2025-11-26 |
4 |
S |
$37.29 |
$192,640 |
D/D |
(5,166) |
78,798 |
|
-15% |
|
Wehrwein Sven |
Director |
|
2025-11-25 |
4 |
S |
$38.00 |
$188,746 |
D/D |
(4,967) |
34,374 |
|
-8% |
|
Wehrwein Sven |
Director |
|
2025-11-25 |
4 |
OE |
$19.95 |
$99,092 |
D/D |
4,967 |
39,341 |
|
- |
|
Wehrwein Sven |
Director |
|
2025-11-24 |
4 |
S |
$37.32 |
$187,832 |
D/D |
(5,033) |
34,374 |
|
-10% |
|
Wehrwein Sven |
Director |
|
2025-11-24 |
4 |
OE |
$19.95 |
$100,408 |
D/D |
5,033 |
39,407 |
|
- |
|
Yuen Maggie |
Director |
|
2025-11-21 |
4 |
S |
$35.72 |
$107,160 |
D/D |
(3,000) |
11,371 |
|
-14% |
|
Carrel Michael H |
President, CEO, & Director |
|
2025-11-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
691,377 |
|
- |
|
Noznesky Justin J |
Chief Mktg & Strategy Officer |
|
2025-09-12 |
4 |
S |
$36.30 |
$108,900 |
D/D |
(3,000) |
83,964 |
|
-18% |
|
Wehrwein Sven |
Director |
|
2025-08-22 |
4 |
S |
$37.00 |
$185,000 |
D/D |
(5,000) |
34,374 |
|
-10% |
|
Wehrwein Sven |
Director |
|
2025-08-22 |
4 |
OE |
$19.95 |
$99,750 |
D/D |
5,000 |
39,374 |
|
- |
|
Wehrwein Sven |
Director |
|
2025-08-19 |
4 |
S |
$36.00 |
$180,000 |
D/D |
(5,000) |
34,374 |
|
-16% |
|
Wehrwein Sven |
Director |
|
2025-08-19 |
4 |
OE |
$19.95 |
$99,750 |
D/D |
5,000 |
39,374 |
|
- |
|
Carrel Michael H |
President, CEO, & Director |
|
2025-08-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
697,377 |
|
- |
|
Groves Regina E |
Director |
|
2025-08-06 |
4 |
S |
$36.82 |
$90,283 |
D/D |
(2,452) |
33,715 |
|
-13% |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2025-08-05 |
4 |
S |
$36.58 |
$91,450 |
D/D |
(2,500) |
71,872 |
|
-10% |
|
Carrel Michael H |
President, CEO, & Director |
|
2025-06-30 |
4 |
A |
$25.84 |
$21,240 |
D/D |
822 |
707,377 |
|
- |
|
Seith Douglas J |
Chief Operating Officer |
|
2025-06-30 |
4 |
A |
$25.84 |
$14,212 |
D/D |
550 |
184,113 |
|
- |
|
Privitera Salvatore |
Chief Technical Officer |
|
2025-06-30 |
4 |
A |
$25.84 |
$21,240 |
D/D |
822 |
125,587 |
|
- |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2025-06-30 |
4 |
A |
$25.84 |
$21,240 |
D/D |
822 |
74,372 |
|
- |
|
Dahlquist Karl S. |
Chief Legal Officer |
|
2025-06-30 |
4 |
A |
$25.84 |
$21,240 |
D/D |
822 |
68,551 |
|
- |
|
Doraiswamy Vinayak |
Chief Scientific Officer |
|
2025-05-28 |
4 |
S |
$33.44 |
$83,600 |
D/D |
(2,500) |
73,550 |
|
-4% |
|
White Robert S. |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
112,174 |
|
- |
|
Groves Regina E |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
36,167 |
|
- |
|
Wehrwein Sven |
Director |
|
2025-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,401 |
34,374 |
|
- |
|
540 Records found
|
|
Page 1 of 22 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|